Condition
Necator Americanus Infection
Total Trials
6
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (5)
P 3 (1)
Trial Status
Completed4
Not Yet Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05372068Not ApplicableActive Not Recruiting
Cement flooRs AnD chiLd hEalth (CRADLE)
NCT06478498Not ApplicableNot Yet RecruitingPrimary
Immune Responses in the Skin After Hookworm Infection
NCT03126552Not ApplicableCompletedPrimary
Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical Center
NCT03257072Not ApplicableCompletedPrimary
Repeated Controlled Human Hookworm Infection
NCT03702530Not ApplicableCompletedPrimary
Immunisation, Treatment and Controlled Human Hookworm Infection
NCT01350271Phase 3CompletedPrimary
Comparative Efficacy of Different Mebendazole Polymorphs in the Treatment of Soil-transmitted Helminth Infections
Showing all 6 trials